Omeros: Novo Nordisk's Licensing Deal Sends Shares Soaring, Makes Bull Case
If you are interested in keeping up to date with stocks making moves within the biotech, pharma, and healthcare industries and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The shares of Omeros Corporation (NASDAQ: OMER ) were soaring in value yesterday, up >150% on the day, rising to a value of $10.40 per share, their highest value since January.The group is for both novice and exper ...